Shapir Engineering and Industry Ltd
Udi Granot is a seasoned professional in business development and consultancy with extensive experience spanning various industries. Currently engaged as a Constant Learner at BizDevExec Club since January 2019, Granot previously held roles such as Business Development Consultant at Qualifire, specializing in enhancing the quality of AI-generated content, and Business Specialist at Livia, which developed an FDA-approved medical device for menstrual pain relief using SmartWave™ technology. Granot's experience also includes serving as Chief Executive Officer at Quze.ai, Vice President of Business Development at mathematic.ai, and Strategy & Business Development Executive at Q-nomy, Inc., where strategic partnerships with major firms produced significant revenue. Earlier career highlights include consulting roles at Accellero Systems Ltd. and Tikal Knowledge Ltd. Granot holds a Bachelor's degree in Political Science and Government from The Hebrew University of Jerusalem.
This person is not in any offices
Shapir Engineering and Industry Ltd
Shapir Engineering and Industry Ltd is an Israel-based company engaged in the engineering and construction sector. In the Development division it initiates projects such as housing and apartments, commercial offices, organizations and parking, where these projects are self financed, planned, constructed, and managed by the constructor. Its Industry division includes a number of subdivisions, as follows: manufacturing and supply of aggregates and road materials, manufacturing of concrete, manufacturing of concrete fabricated plant, as well as manufacturing and supply of asphalt for road paving. In the Engineering division it is engaged in the construction, infrastructure development and civil engineering fields through Shapir civil engineering, which constructs bridges, intersections, paving roads, sea works, public housing, industrial construction and government projects. Furthermore the Company transports quarry, asphalt, and bedding for roads through its subsidiary Merchavim.